09.03.2013 Views

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

Inhibitor SourceBook™ Second Edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Myosin Light Chain Kinase (MLCK) <strong>Inhibitor</strong>s<br />

Myosin light chain kinase (MLCK), a Ca 2+ -calmodulin<br />

dependent multi-functional enzyme, plays a critical<br />

role in the regulation of smooth muscle contraction and<br />

cellular migration. It regulates the contractile interaction<br />

between actin microfilaments and conventional smooth<br />

muscle and non-muscle myosin II. MLCK is composed of<br />

an N-terminal actin-binding domain, a central kinase<br />

domain, and a C-terminal myosin-binding domain. The<br />

kinase domain activates the interaction of smooth-muscle<br />

myosin with actin by phosphorylating the myosin light<br />

chain. MLCK phosphorylates a specific site on the Nterminus<br />

of the regulatory light chain of myosin II. This<br />

phosphorylation is responsible for coupling increased Ca 2+<br />

concentration with smooth muscle contraction.<br />

In the presence of Ca 2+ , the C-terminal domain of<br />

calmodulin binds to the N-terminus of the calmodulinbinding<br />

sequence of MLCK followed by the binding<br />

Myosin Light Chain Kinase (MLCK) <strong>Inhibitor</strong>s<br />

Calbiochem • <strong>Inhibitor</strong> SourceBook<br />

Phosphorylation/Dephosphorylation<br />

of the N-terminal domain to the C-terminus of the<br />

calmodulin-binding sequence. MLCK is reported to<br />

bind the actin filament in a manner that also allows the<br />

simultaneous binding of the other major thin filament<br />

components; calponin, tropomyosin, etc. The binding site<br />

is suggested to be on the outside of sub-domain 1. There<br />

is approximately one MLCK molecule for every 100 actin<br />

molecules in smooth muscle and each MLCK contains at<br />

least three of the DFRXXL motifs allowing each molecule<br />

to bind three actins (K d = 4 mM).<br />

References:<br />

Kamm, K.E., and Stull, J.T. 200 . J. Biol. Chem. 276, 4527.<br />

Hatch, V., et al. 200 . J. Cell Biol. 154, 6 .<br />

Smith, L., and Stull, J.T. 2000. FEBS let. 480, 298.<br />

Le, L-H., et al. 999. Proc. Natl. Acad. Sci. USA 96, 6666.<br />

Sellers, J.R., and Pato, M.D. 984. J.Biol.Chem. 259, 7740.<br />

Product Cat. No. Comments Size Price<br />

A3, Hydrochloride 100122 [N-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide, HCl]<br />

A shorter alkyl chain derivative of W-7 (Cat. No. 68 629) that inhibits MLCK<br />

(K i = 7.4 mM), CK I (K i = 80 mM), CK II (K i = 5. mM), PKA (K i = 4.3 mM), PKC (K i = 47 mM),<br />

and PKG (K i = 3.8 mM).<br />

Gö 7874, Hydrochloride 365252 A potent and selective inhibitor of protein kinase C (IC 50 = 4 nM for rat brain PKC).<br />

Inhibits protein kinase A (IC 50 = 5 0 nM), protein kinase G (IC 50 = 4.8 mM), and myosin<br />

light chain kinase (IC 50 = 20 nM) at much higher concentrations.<br />

K-252a, Nocardiopsis<br />

sp.<br />

InSolution K-252a,<br />

Nocardiopsis sp.<br />

K-252b, Nocardiopsis<br />

sp.<br />

420298 A cell-permeable inhibitor of MLCK (K i = 7 nM), CaM kinase II (K i = .8 nM), PKC<br />

(K i = 25 nM), and PKG (K i = 20 nM). Also acts as a potent inhibitor (IC 50 = 3 nM) of the<br />

protein tyrosine kinase activity of the NGF receptor gp 40 trk .<br />

0 mg $90<br />

500 mg $ 00<br />

00 mg $ 33<br />

420297 A mM ( 00 mg/2 4 ml) solution of K-252a (Cat. No. 420298) in anhydrous DMSO. 00 mg $ 28<br />

420319 A non-selective inhibitor of MLCK (K i = 47 nM), PKA (K i = 90 nM), PKC (K i = 20 nM),<br />

and PKG (K i = 00 nM).<br />

ML-7, Hydrochloride 475880 [1-(5-Iodonaphthalene-1-sulfonyl)homopiperazine, HCl]<br />

A cell-permeable, potent and selective inhibitor of MLCK (K i = 300 nM).<br />

Inhibits PKA (K i = 2 mM) and PKC (K i = 42 mM) at much higher concentrations.<br />

ML-9, Hydrochloride 475882 [1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl]<br />

A cell-permeable inhibitor of MLCK (K i = 3.8 mM), PKA (K i = 32 mM), and<br />

PKC (K i = 54 mM).<br />

Myosin Light Chain<br />

Kinase <strong>Inhibitor</strong> Peptide<br />

8<br />

475981 (H-RKKYKYRRK-NH 2 ; MLCK <strong>Inhibitor</strong> Peptide 18)<br />

A highly basic nonapeptide that acts as a selective inhibitor of MLCK (IC 50 = 50 nM).<br />

Does not block calmodulin (CaM) or inhibit the activities of CaM Kinase II or PKA.<br />

Piceatannol 527948 (trans-3,3´,4,5´-Tetrahydroxystilbene)<br />

A plant metabolite that preferentially inhibits the activity of p72 Syk (IC 50 ~ 0 mM).<br />

Also acts as an inhibitor of rat liver PKA catalytic subunit (IC 50 = 3 mM), PKC<br />

(IC 50 = 8 mM), and MLCK (IC 50 = 2 mM).<br />

Staurosporine,<br />

Streptomyces sp.<br />

More online... www.calbiochem.com/inhibitors/MLCK<br />

569397 A potent, cell-permeable broad-spectrum inhibitor of protein kinases. Inhibits MLCK<br />

(IC 50 = .3 nM), CaM kinase (IC 50 = 20 nM), PKA (IC 50 = 7 nM), PKC (IC 50 = 700 pM),<br />

and PKG (IC 50 = 8.5 nM).<br />

50 mg<br />

00 mg<br />

$76<br />

$ 33<br />

mg $99<br />

mg $99<br />

5 mg $ 6<br />

00 mg<br />

250 mg<br />

mg $4<br />

$ 43<br />

$302<br />

Technical Support<br />

Phone 800 628 8470<br />

E-mail calbiochem@emdbiosciences.com<br />

29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!